Singapore legislation
Regulation 13C
of Central Provident Fund (Medisave Account Withdrawals) Regulations 2001
Regulation 13C
Out‑patient repetitive transcranial magnetic stimulation in approved clinics or approved hospitals
Subregulation 1
Subject to paragraphs (2) and (3), a member may withdraw moneys from the member’s medisave account for the payment of each course of repetitive transcranial magnetic stimulation that starts on or after 1 October 2025, received by the member or the member’s dependant as an out‑patient in an approved clinic or approved hospital.
Subregulation 2
Paragraph (1) —
applies to not more than 2 courses of repetitive transcranial magnetic stimulation received by each patient during the patient’s lifetime for which withdrawals were made under paragraph (1) by the member or any other member; and
does not apply to any subsequent course of repetitive transcranial magnetic stimulation received by a patient that starts within 120 days after the end of the patient’s earlier course of repetitive transcranial magnetic stimulation for which a withdrawal was made under paragraph (1) by the member or any other member.
Subregulation 3
Subject to regulations 4, 21B, 21C, 21D and 21E, the amount the member may withdraw under paragraph (1) for payment of each course of repetitive transcranial magnetic stimulation received by each patient must not exceed the lowest of the following amounts:
the specified amount for the course of repetitive transcranial magnetic stimulation computed in accordance with paragraph (4);
the total expenditure for the course of repetitive transcranial magnetic stimulation;
the total credit balance in the member’s medisave account.
Subregulation 4
In paragraph (3)(a), the specified amount is computed in accordance with the formula A × B, where —
A is the number of treatment sessions of repetitive transcranial magnetic stimulation received by the patient, not exceeding the following number of sessions:
for the patient’s earlier course of repetitive transcranial magnetic stimulation —
24 sessions, if the patient has received 24 or more sessions of repetitive transcranial magnetic stimulation in that course before 1 June 2026; or
30 sessions, in any other case;
for the patient’s subsequent course of repetitive transcranial magnetic stimulation — 30 sessions; and
B is the cost of each treatment session not exceeding $15 for each treatment session.
Subregulation 5
For the purposes of this regulation, the start and end of a course of repetitive transcranial magnetic stimulation is determined by the approved clinic or approved hospital based on the advice of an approved medical practitioner.